技术文章

Recombinant Human IL31RA Protein: Research Guide & Protocol

Recombinant Human IL31RA Protein is a purified, bioactive receptor subunit used to study IL-31-mediated signaling pathways relevant to inflammatory and allergic diseases.

Protein Name
Recombinant Human IL31RA Protein
Also Known As
Interleukin-31 Receptor Subunit Alpha; IL-31 RA; IL31RA; GPL
Biological Function
Subunit of the IL-31 receptor complex; binds IL-31 in concert with OSMRβ to activate JAK/STAT signaling involved in inflammation, pruritus, and tissue remodeling
Expression System
Typically produced in mammalian or insect expression systems to preserve glycosylation and bioactivity; confirm specific system on product datasheet
Primary Applications
ELISA, cell-based binding assays, receptor-ligand interaction studies, Western blot, SDS-PAGE quality verification
Storage Recommendation
Store lyophilized protein at -20 °C to -80 °C; avoid repeated freeze-thaw cycles; reconstitute in sterile buffer as directed on datasheet

Biological Background of IL31RA

Interleukin-31 receptor subunit alpha (IL31RA), also referred to as GPL or IL-31 RA, is a type I cytokine receptor that serves as one of two subunits forming the functional IL-31 receptor complex. The second subunit is oncostatin M receptor beta (OSMRβ). Together, IL31RA and OSMRβ bind their cognate ligand, IL-31, a cytokine primarily secreted by activated CD4+ T helper type 2 (Th2) cells.

Upon IL-31 binding, the receptor complex initiates intracellular signaling through the Janus kinase (JAK) / signal transducer and activator of transcription (STAT) pathway, as well as MAPK and PI3K cascades. These downstream events regulate gene expression programs associated with inflammation, epithelial barrier dysfunction, pruritus (itch), and tissue remodeling. IL31RA is expressed on multiple cell types including keratinocytes, dorsal root ganglion neurons, airway epithelial cells, monocytes, and macrophages, underlining its roles in skin homeostasis and atopic diseases.

Dysregulated IL-31/IL31RA signaling has been implicated in atopic dermatitis, asthma, allergic rhinitis, and certain hematological malignancies. IL31RA has consequently become an important target for therapeutic antibodies and a key protein of interest for basic and translational research into type 2 inflammatory diseases.

Protein Specifications and Quality Control

Recombinant Human IL31RA Protein (Aladdin SKU: rp368365) is produced using a recombinant expression system designed to yield a soluble, bioactive extracellular domain of human IL31RA. The following specifications are typical for recombinant receptor proteins of this class; always confirm exact values against the current product datasheet before use.

  • Protein form: Typically the extracellular domain of human IL31RA, often fused to an affinity tag (e.g., His-tag or Fc-tag) to facilitate purification and detection.
  • Purity: ≥90% as assessed by SDS-PAGE under reducing conditions; endotoxin levels controlled to minimize interference in cell-based assays.
  • Formulation: Usually supplied as a lyophilized powder or liquid in a physiological buffer (e.g., PBS with carrier protein such as BSA). Refer to the datasheet for lot-specific details.
  • Biological activity: Confirmed by a functional binding or inhibition assay demonstrating interaction with IL-31 ligand; specific ED50 values are lot-dependent and stated on the Certificate of Analysis (CoA).

Aladdin Scientific performs SDS-PAGE and, where applicable, functional bioassays as standard quality control steps. Lot-specific CoA documents are available upon request.

Reconstitution, Storage, and Handling Protocol

Proper reconstitution and storage are critical to maintaining the bioactivity of Recombinant Human IL31RA Protein. Follow the steps below and always cross-reference the product-specific datasheet for lot-dependent instructions.

Reconstitution

  1. Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) before opening to collect lyophilized material at the bottom.
  2. Reconstitute in sterile, deionized water or the buffer recommended on the datasheet (typically PBS, pH 7.4) to a concentration of 0.1–1.0 mg/mL. Adding a carrier protein (0.1% BSA) is recommended if the protein will be used at low concentrations or stored for extended periods.
  3. Gently mix by pipetting or by rolling the vial. Do NOT vortex, as this may cause protein denaturation and aggregation.
  4. Allow the protein to dissolve completely at room temperature for 10 minutes, then place on ice.

Storage Conditions

  • Short-term (≤1 week): Store at 4 °C.
  • Long-term: Aliquot into single-use volumes and store at -20 °C or -80 °C. Aliquoting prevents loss of activity due to repeated freeze-thaw cycles.
  • Avoid repeated freeze-thaw cycles; each cycle can significantly reduce bioactivity.

Working Conditions

  • Thaw aliquots on ice before use.
  • Keep protein on ice during experimental setup.
  • Do not expose to temperatures above 37 °C for extended periods.

Experimental Applications and Assay Guidance

Recombinant Human IL31RA Protein is suitable for a range of in vitro research applications. Below are the most common uses and practical guidance for each.

ELISA and Binding Assays

IL31RA is commonly used as a capture or detection reagent in sandwich ELISA formats designed to quantify IL-31 ligand. As a coating antigen, it can also be used to screen for IL31RA-binding antibodies or small molecules. Use at concentrations typically in the range of 0.5–2 µg/mL for plate coating; optimize empirically for each assay system.

Receptor-Ligand Interaction Studies

Surface plasmon resonance (SPR), bio-layer interferometry (BLI), and co-immunoprecipitation (co-IP) assays can employ recombinant IL31RA to characterize binding kinetics (KD, kon, koff) between IL31RA and IL-31 or candidate blocking molecules. Ensure the protein is free of aggregates before use by filtering through a 0.22 µm membrane or performing size-exclusion chromatography.

Cell-Based Functional Assays

When used as a soluble receptor (decoy receptor approach), recombinant IL31RA extracellular domain can neutralize IL-31 bioactivity in cell culture systems. This approach helps validate downstream signaling (JAK1/2, STAT3/5 phosphorylation) and establishes IL-31 dependency in a cellular model of interest.

Western Blot and SDS-PAGE

The purified protein can serve as a positive control or molecular weight marker in Western blot experiments using anti-IL31RA antibodies. Run under both reducing and non-reducing conditions to assess disulfide bond integrity.

Safety, Regulatory Status, and Ordering Information

Research Use Only (RUO): Recombinant Human IL31RA Protein (SKU: rp368365) is intended for in vitro research purposes only. It is not approved or validated for use in diagnostic, therapeutic, or veterinary applications.

Safety Handling: As with all protein reagents, handle with standard laboratory precautions. Wear appropriate personal protective equipment (gloves, lab coat, eye protection). Although IL31RA itself is not classified as a biohazardous material, follow institutional biosafety guidelines. Consult the Safety Data Sheet (SDS) for full hazard information.

Disposal: Dispose of protein solutions and contaminated materials according to local institutional and regulatory guidelines for biological laboratory waste.

Ordering: Recombinant Human IL31RA Protein is available from Aladdin Scientific under SKU rp368365. Contact your local Aladdin representative or visit the Aladdin Scientific website to request a quote, access the current datasheet, or obtain a Certificate of Analysis for a specific lot.

Frequently asked questions

What is the biological function of IL31RA and why is it relevant to disease research?

IL31RA is a subunit of the heterodimeric IL-31 receptor complex. Upon binding IL-31 (together with OSMRβ), it activates JAK/STAT, MAPK, and PI3K signaling pathways that drive inflammation, itch, and epithelial remodeling. Dysregulated IL-31/IL31RA signaling is associated with atopic dermatitis, asthma, and allergic rhinitis, making IL31RA a key target for therapeutic and mechanistic research.

How should I reconstitute and store Recombinant Human IL31RA Protein to preserve bioactivity?

Reconstitute the lyophilized protein in sterile PBS (pH 7.4) or the buffer specified on the datasheet, at 0.1–1.0 mg/mL. Add 0.1% BSA as a carrier if using at low concentrations. Aliquot into single-use volumes and store at -80 °C for long-term use. Avoid repeated freeze-thaw cycles and do not vortex, as these can cause aggregation and loss of activity.

Which assay formats are compatible with Recombinant Human IL31RA Protein?

This protein is suitable for ELISA (as coating antigen or detection reagent), receptor-ligand binding studies via SPR or BLI, cell-based functional neutralization assays, and Western blot as a positive control. Always optimize protein concentrations empirically for each specific assay system and refer to the product datasheet for recommended conditions.

Is Recombinant Human IL31RA Protein suitable for in vivo or diagnostic use?

No. This product is designated Research Use Only (RUO) and is intended solely for in vitro laboratory research. It has not been validated or approved for diagnostic, therapeutic, or veterinary applications. For any intended non-research application, appropriate regulatory submissions and validations would be required.

How can I verify the quality and purity of the IL31RA protein I receive?

Each lot is accompanied by a Certificate of Analysis (CoA) detailing purity (by SDS-PAGE), endotoxin levels, and bioactivity test results. You can request the lot-specific CoA from Aladdin Scientific. Upon receipt, you may also run SDS-PAGE under reducing conditions to confirm the expected molecular weight band and assess purity independently.

References

  1. Dillon SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nature Immunology. 2004;5(7):752-760. doi:10.1038/ni1084
  2. Kasaian MT, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology. 2011;127(2):418-425.
  3. Zhang Q, et al. Structures of the IL-31 receptor: insights into the mechanisms of cytokine signal transduction. Nature Structural & Molecular Biology. 2018;25(12):1071-1081.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human IL31RA Protein: Research Guide & Protocol》. 阿拉丁知识库,更新于 2026年11月2日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-il31ra-protein-research-guide-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助